Video

Video Report: What's the Future of Prostate Cancer Care?

Publish date: June 5, 2011

 

Dr. Walter Stadler of the University of Chicago speaks about the changing landscape of prostate cancer care for physicians and patients. Newer modalities mean growing complexities in treating prostate disease.

Recommended Reading

CMS: Medicare to Cover On-Label Use of Provenge
MDedge Hematology and Oncology
Limited Benefit Seen in 20-Year Prostate Cancer Screening Study
MDedge Hematology and Oncology
NCCN Tightens Active Surveillance in Prostate Cancer Guidelines
MDedge Hematology and Oncology
FDA Approves Abiraterone for Castration-Resistant Prostate Cancer
MDedge Hematology and Oncology
Radical Prostatectomy Continues to Cut Mortality After 15 Years
MDedge Hematology and Oncology
Two-Tiered Prostate Cancer Surveillance May Curb Overtreatment
MDedge Hematology and Oncology
Intermittent Androgen Suppression Offers Small Gains for Prostate Cancer Patients
MDedge Hematology and Oncology
Abiraterone Prolongs Survival in Castration-Resistant Prostate Cancer
MDedge Hematology and Oncology
PIVOT Trial: No Overall Benefit to Radical Prostatectomy for Localized Prostate Cancer
MDedge Hematology and Oncology
Rare case of renal cell carcinoma presenting as a cutaneous horn
MDedge Hematology and Oncology